HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H H Pas Selected Research

Junctional Epidermolysis Bullosa (Epidermolysis Bullosa Letalis)

8/2016New versatile monoclonal antibodies against type XVII collagen endodomain for diagnosis and subtyping COL17A1-associated junctional epidermolysis bullosa.
8/2009Adhesive stripping to remove epidermis in junctional epidermolysis bullosa for revertant cell therapy.
5/2007Localized and generalized forms of blistering in junctional epidermolysis bullosa due to COL17A1 mutations in the Netherlands.
9/2004Features of epidermolysis bullosa simplex due to mutations in the ectodomain of type XVII collagen.
6/2001Truncated typeXVII collagen expression in a patient with non-herlitz junctional epidermolysis bullosa caused by a homozygous splice-site mutation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H H Pas Research Topics

Disease

18Bullous Pemphigoid (Pemphigoid)
10/2021 - 01/2001
10Pemphigus (Pemphigus Vulgaris)
04/2021 - 01/2001
7Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa)
01/2022 - 02/2000
5Neoplasms (Cancer)
10/2021 - 09/2010
5Junctional Epidermolysis Bullosa (Epidermolysis Bullosa Letalis)
08/2016 - 06/2001
3Blister (Bulla)
04/2021 - 09/2004
3Autoimmune Diseases (Autoimmune Disease)
09/2010 - 07/2004
3Benign Mucous Membrane Pemphigoid (Cicatricial Pemphigoid)
09/2010 - 02/2000
2Linear IgA Bullous Dermatosis
09/2010 - 04/2001
2Epidermolysis Bullosa
09/2005 - 06/2001
1Pruritus (Itching)
04/2021
1Acantholysis
12/2012
1lethal acantholytic Epidermolysis bullosa
06/2010
1Epidermolysa bullosa simplex and limb girdle muscular dystrophy
10/2009
1Cicatrix (Scar)
08/2009
1Oral Lichen Planus
09/2007
1Palmoplantar Keratoderma (Keratosis Palmaris et Plantaris)
07/2007
1Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara)
09/2004
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
07/2004
1Eczema
03/2002
1Vesiculobullous Skin Diseases (Subcorneal Pustular Dermatosis)
12/2001
1Renal Cell Carcinoma (Grawitz Tumor)
04/2001
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2000

Drug/Important Bio-Agent (IBA)

10AutoantibodiesIBA
04/2021 - 02/2000
10Immunoglobulin G (IgG)IBA
01/2020 - 02/2000
9AntibodiesIBA
01/2020 - 12/2001
7AntigensIBA
10/2019 - 01/2001
6Immunoglobulin A (IgA)IBA
07/2011 - 04/2001
5SaltsIBA
01/2022 - 07/2004
4Collagen Type VIIIBA
01/2022 - 02/2000
4EnzymesIBA
04/2021 - 07/2004
4ImmunosorbentsIBA
04/2021 - 07/2004
4Proteins (Proteins, Gene)FDA Link
10/2019 - 06/2001
4Collagen Type XVIIIBA
08/2016 - 06/2001
4DesmogleinsIBA
11/2013 - 04/2007
3Matrix Metalloproteinases (MMPs)IBA
10/2021 - 10/2011
2KalininIBA
10/2021 - 02/2000
2CollagenIBA
01/2018 - 06/2001
2PlectinIBA
10/2009 - 09/2005
1Immunoglobulin E (IgE)IBA
04/2021
1Complement System Proteins (Complement)IBA
01/2017
1Monoclonal AntibodiesIBA
08/2016
1PlakinsIBA
11/2013
1Rituximab (Mabthera)FDA Link
02/2012
1Pharmaceutical PreparationsIBA
02/2012
1Desmosomal CadherinsIBA
09/2011
1Toll-Like Receptor 7IBA
01/2011
1Imiquimod (Aldara)FDA LinkGeneric
01/2011
1PlakophilinsIBA
09/2010
1Peptides (Polypeptides)IBA
09/2010
1Desmoplakins (Desmoplakin)IBA
06/2010
1Immunodominant EpitopesIBA
10/2009
1DesmocollinsIBA
07/2007
1Amino AcidsFDA Link
02/2004
1AllergensIBA
03/2002
1Interferon-alpha (Interferon Alfa)IBA
04/2001
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2001
1laminin alpha 3IBA
02/2000
1EpitopesIBA
02/2000
1Messenger RNA (mRNA)IBA
01/2000

Therapy/Procedure

1Cell- and Tissue-Based Therapy (Cell Therapy)
08/2009
1Transplantation
08/2009
1Palliative Care (Palliative Therapy)
04/2001